{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urinary+Bladder+Diseases%5CUrologic+Diseases&page=55", "query": { "condition": "Urinary Bladder Diseases\\Urologic Diseases", "page": 55 }, "page_size": 10 }, "pagination": { "page": 55, "page_size": 10, "total_count": 1585, "total_pages": 159, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urinary+Bladder+Diseases%5CUrologic+Diseases&page=56&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urinary+Bladder+Diseases%5CUrologic+Diseases&page=54&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T16:29:50.564Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01824303", "title": "Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Interstitial Cystitis" ], "interventions": [ { "name": "LiRIS 400 mg", "type": "DRUG" }, { "name": "LiRIS Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 31, "start_date": "2013-03", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-01-26", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 15, "location_summary": "Glendora, California • Daytona Beach, Florida • Kansas City, Kansas + 12 more", "locations": [ { "city": "Glendora", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01824303" }, { "nct_id": "NCT06929286", "title": "A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Muscle Invasive Bladder Cancer" ], "interventions": [ { "name": "Nadofaragene Firadenovec", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 125, "start_date": "2025-04-11", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 9, "location_summary": "Baltimore, Maryland • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06929286" }, { "nct_id": "NCT00004095", "title": "Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bladder Cancer", "Breast Cancer", "Colorectal Cancer", "Kidney Cancer", "Lung Cancer", "Pancreatic Cancer" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "irinotecan hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 38, "start_date": "1999-08", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004095" }, { "nct_id": "NCT02897765", "title": "A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Urinary Bladder Cancer", "Bladder Tumors", "Transitional Cell Carcinoma of the Bladder", "Malignant Melanoma", "Melanoma", "Skin Cancer", "Carcinoma, Non-Small-Cell Lung", "Lung Cancer" ], "interventions": [ { "name": "NEO-PV-01", "type": "BIOLOGICAL" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Adjuvant", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "BioNTech US Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2016-10", "completion_date": "2020-05", "has_results": false, "last_update_posted_date": "2021-02-25", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 9, "location_summary": "Duarte, California • Los Angeles, California • San Francisco, California + 4 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02897765" }, { "nct_id": "NCT07568444", "title": "Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer (Adenocarcinoma)", "Bladder Cancer", "Kidney Cancers", "Testis Cancer" ], "interventions": [ { "name": "Pub2Post", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2025-01-16", "completion_date": "2025-02-27", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07568444" }, { "nct_id": "NCT00055601", "title": "Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Radical cystectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "120 Years", "sex": "ALL", "summary": "Up to 120 Years" }, "enrollment_count": 97, "start_date": "2002-12", "completion_date": "2018-05-14", "has_results": true, "last_update_posted_date": "2018-06-15", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 2, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00055601" }, { "nct_id": "NCT06918067", "title": "Comparison of Urinary Flow Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urinary Retention" ], "interventions": [ { "name": "Coloplast Micro Zone Luja Female Catheter", "type": "DEVICE" }, { "name": "Coloplast SpeediCath Female Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 17, "start_date": "2025-11-06", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06918067" }, { "nct_id": "NCT00830479", "title": "Study of Endoscopic Versus Open Surgery for Urinary Reflux", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vesicoureteral Reflux" ], "interventions": [ { "name": "Anti-reflux surgery", "type": "PROCEDURE" }, { "name": "Endoscopic injection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "11 Years", "sex": "ALL", "summary": "Up to 11 Years" }, "enrollment_count": 0, "start_date": "2009-01", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2011-08-12", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00830479" }, { "nct_id": "NCT01611662", "title": "Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Distal Urethral Cancer", "Proximal Urethral Cancer", "Squamous Cell Carcinoma of the Bladder", "Stage II Bladder Cancer", "Stage III Bladder Cancer", "Urethral Cancer Associated With Invasive Bladder Cancer" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "therapeutic conventional surgery", "type": "PROCEDURE" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Fox Chase Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2012-05-29", "completion_date": "2019-01-22", "has_results": true, "last_update_posted_date": "2019-07-29", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01611662" }, { "nct_id": "NCT02400034", "title": "Comparing Voiding Trials After Midurethral Sling for Stress Incontinence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress Urinary Incontinence", "Urethral Hypermobility", "Cystocele" ], "interventions": [ { "name": "Voiding trial", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 112, "start_date": "2015-03", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2016-10-21", "last_synced_at": "2026-11-09T16:29:50.564Z", "location_count": 1, "location_summary": "Great Neck, New York", "locations": [ { "city": "Great Neck", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02400034" } ] }